Table 2.

Treatment Outcomes to Intravitreal Bevacizumab Injection and Transpupillary Thermotherapy Regarding Response of Subfoveal fluid and Visual Acuity

SFF; BCVA	IVB	TTT
Complete resolution; Improved, No.(%)	2 (14.3%); 2 (22%)	3 (75%); 3 (75%)
Partial resolution; Stable, No.(%)	3 (21.4%); 2 (22%)	1 (25%); 1 (25%)
No change; Worsen, No.(%)	9 (64.3%); 5 (55.6%)	0 (0%); 0 (0%)
Total (No.)	14; 9	4; 4

SFF subfoveal fluid, BCVA best corrected visual acuity, IVB intravitreal bevacizumab injection, TTT transpupillary thermotherapy, No. number